Sichao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sichao Wang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Zhen Gao
Department of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2 shared publications - Abraham Ka Chung Wai
The University of Hong Kong
1 shared publication - Bin Zhang
The First Department of Breast Surgery, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China; Tianjin's Clinical Research Center for Cancer, Tianjin, China; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China
1 shared publication - Chen Chen
Shanghai Pulmonary Hospital, Shanghai/CN
1 shared publication D. Yue
Tianjin Medical University Cancer Institute and Hospital, Tianjin/CN
1 shared publication- Dan-Yang Zheng
Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
1 shared publication
Latest Publications
- Open Access
- 15 February 2026
- Published by Elsevier in Journal of the National Cancer Center
- Vol. 6 (2) , 185-188
Differential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China
- 15 February 2026
- Published by Elsevier in Journal of the National Cancer Center
- Vol. 6 (2) , 185-188
Open AccessDifferential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China
- 31 October 2023
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 18 (11) , S562
EP07.05-11 Efficacy and Safety of Osimertinib Therapy in High-Risk Stage I EGFRm NSCLC after R0 Resection(OSTAR): A Prospective, Single-Arm Study
- 31 October 2023
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 18 (11) , S562
EP07.05-11 Efficacy and Safety of Osimertinib Therapy in High-Risk Stage I EGFRm NSCLC after R0 Resection(OSTAR): A Prospective, Single-Arm Study
- Open Access
- 14 October 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 39, 100927
Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
- 14 October 2023
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 39, 100927
Open AccessDoes nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
- 13 October 2011
- Published by Wiley in ChemInform
- Vol. 42 (45)
ChemInform Abstract: Na2CsBe6B5O15: An Alkaline Beryllium Borate as a Deep-UV Nonlinear Optical Crystal.
Transparent and colorless single crystals of the title compound are obtained by controlled cooling of a homogenized melt of Na2CO3, Cs2CO3, BeO, and B2O3 (Pt crucible, 1000 °C).
- 13 October 2011
- Published by Wiley in ChemInform
- Vol. 42 (45)
ChemInform Abstract: Na2CsBe6B5O15: An Alkaline Beryllium Borate as a Deep-UV Nonlinear Optical Crystal.
Transparent and colorless single crystals of the title compound are obtained by controlled cooling of a homogenized melt of Na2CO3, Cs2CO3, BeO, and B2O3 (Pt crucible, 1000 °C).